Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,421,914
-
Share change
-
+858,994
-
Total reported value
-
$98,820,000
-
Price per share
-
$13.32
-
Number of holders
-
53
-
Value change
-
+$12,021,505
-
Number of buys
-
28
-
Number of sells
-
26
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q4 2014
As of 31 Dec 2014,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,421,914 shares.
The largest 10 holders included
BVF INC/IL, SENZAR ASSET MANAGEMENT, LLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., VANGUARD GROUP INC, WALL STREET ASSOCIATES, UBS Group AG, QVT Financial LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.